PART IV
APPENDICES
I. Financial Statements by Fund
Statement of Financial Position as at December 31, 2024 A-1 to 3
Statement of Financial Performance For the Year Ended December 31, 2024 B-1 to 3
Statement of Changes in Net Assets / Equity C-1 to 3
Statement of Cash Flows For the Year Ended December 31, 2024 D-1 to 3
Statement of Comparison of Budget and Actual Amounts E-1 to 2
II. Summary of Statement of Appropriations, Allotments, Obligations and
Balances
General Fund – Current Legislative Appropriations F-1.1
General Fund – Continuing Appropriations F-1.2
Special Education Fund - Current Legislative Appropriations F-2.1
Special Education Fund - Continuing Appropriations F-2.2
III. Inventory Purchases Recorded as Outright Expense
Office Supplies Expenses G-1
Accountable Forms Expenses G-2
Animal/Zoological Supplies G-3
Welfare Goods Expenses G-4
Drugs and Medicines Expenses G-5
Medical, Dental and Laboratory Supplies Expenses G-6
Agricultural and Marine Supplies Expenses G-7
Other Supplies and Materials Expenses G-8
IV. Cell Card Allowances Charged Against the Appropriations Office Supplies H
Budget
V. Transportation Allowances Paid to Office Heads With Assigned Vehicles I
Under Their Names
VI. Unimplemented Audit Recommendations in the CY 2023 AAR as of J
August 31, 2024
